drugset / Trial / NCT05376111
Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients
Phase 2
Recruiting
28 enrolled
The First Affiliated Hospital of Soochow University
Affiliated Hospital of Nantong University · collabJining Medical University · collabNorthern Jiangsu People's Hospital · collabSuzhou Hospital of Traditional Chinese Medicine · collabThe First Affiliated Hospital of Bengbu Medical University · collabThe Second People's Hospital of Huai'an · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of venetoclax combined with azacitidine regimen for newly diagnosed T-ALL patients.
Timeline
- Start
- 2022-04-01
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 75 mg/m2 | Subcutaneous |
| Subject | Venetoclax | Small molecule | 400 mg | Oral |